These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. [Infection of hepatitis C virus in patients with chronic renal failure undergoing hemodialysis therapy and staff members]. Miyasaka M Nihon Jinzo Gakkai Shi; 1991 Oct; 33(10):989-99. PubMed ID: 1722830 [TBL] [Abstract][Full Text] [Related]
26. The effect of prior transfusion history on blood donor anti-hepatitis C virus antibody. Mazda T; Nakata K; Ota K; Kaminuma Y; Katayama T Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():183-6. PubMed ID: 7886569 [TBL] [Abstract][Full Text] [Related]
27. [Decreasing the risk of post-transfusion non-A, non-B hepatitis by anti-HCV screening]. Holzberger G; Seidl S; Peschke B; Scheuermann EH; Schoeppe W Beitr Infusionsther; 1992; 30():46-8. PubMed ID: 1284760 [TBL] [Abstract][Full Text] [Related]
28. Antibodies to hepatitis C virus: a cross-sectional study in patients attending a trauma unit or admitted to hospital for elective surgery. García-Bengoechea M; Emparanza JI; Sarriugarte A; Cortés A; Vega JL; González F; Arenas JI Eur J Gastroenterol Hepatol; 1995 Mar; 7(3):237-41. PubMed ID: 7538032 [TBL] [Abstract][Full Text] [Related]
29. Transfusion transmitted infections in patients with hemophilia of Karachi, Pakistan. Borhany M; Shamsi T; Boota S; Ali H; Tahir N; Naz A; Naseer I; Farzana T; Ansari S; Nadeem M; Zia-Ur-Rahman ; Sangji Z Clin Appl Thromb Hemost; 2011; 17(6):651-5. PubMed ID: 21406412 [TBL] [Abstract][Full Text] [Related]
30. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. Alter HJ; Purcell RH; Shih JW; Melpolder JC; Houghton M; Choo QL; Kuo G N Engl J Med; 1989 Nov; 321(22):1494-500. PubMed ID: 2509915 [TBL] [Abstract][Full Text] [Related]
31. Prevalence of hepatitis C antibodies in patients with clotting disorders in Victoria. Relationship with other blood borne viruses and liver disease. Leslie DE; Rann S; Nicholson S; Fairley CK; Gust ID Med J Aust; 1992 Jun; 156(11):789-92. PubMed ID: 1321326 [TBL] [Abstract][Full Text] [Related]
32. Decrease in the prevalence of hepatitis B and a low prevalence of hepatitis C virus infections in the general population of the Seychelles. Bovet P; Yersin C; Herminie P; Lavanchy D; Frei PC Bull World Health Organ; 1999; 77(11):923-8. PubMed ID: 10612888 [TBL] [Abstract][Full Text] [Related]
33. Estimated risk of transmission of hepatitis C virus by blood transfusion. Koerner K; Cardoso M; Dengler T; Kerowgan M; Kubanek B Vox Sang; 1998; 74(4):213-6. PubMed ID: 9691400 [TBL] [Abstract][Full Text] [Related]
34. Hepatitis virus infection (HBV and HCV) in eleven Japanese hemodialysis units. Oguchi H; Miyasaka M; Tokunaga S; Hora K; Ichikawa S; Ochi T; Yamada K; Nagasawa M; Kanno Y; Aizawa T Clin Nephrol; 1992 Jul; 38(1):36-43. PubMed ID: 1499167 [TBL] [Abstract][Full Text] [Related]
35. Viral hepatitis in Nigeria--sickle-cell disease and commercial blood donors. Mutimer DJ; Olomu A; Skidmore S; Olomu N; Ratcliffe D; Rodgers B; Mutimer HP; Gunson BK; Elias E QJM; 1994 Jul; 87(7):407-11. PubMed ID: 7922292 [TBL] [Abstract][Full Text] [Related]
36. Prevalence & significance of hepatitis C virus (HCV) seropositivity in blood donors. Thakral B; Marwaha N; Chawla YK; Saluja K; Sharma A; Sharma RR; Minz RW; Agnihotri SK Indian J Med Res; 2006 Oct; 124(4):431-8. PubMed ID: 17159264 [TBL] [Abstract][Full Text] [Related]
37. Antibody to hepatitis C virus in thalassemia patients. Isahak I; Baharin R; Hakim AS; Abu Bakar M; George E Malays J Pathol; 1993 Jun; 15(1):85-7. PubMed ID: 8277796 [TBL] [Abstract][Full Text] [Related]
38. Low prevalence of anti-hepatitis C virus antibodies in female hemodialysis patients without blood transfusion: a multicenter analysis. Nakayama E; Liu JH; Akiba T; Marumo F; Sato C J Med Virol; 1996 Mar; 48(3):284-8. PubMed ID: 8801291 [TBL] [Abstract][Full Text] [Related]
39. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa. Vermeulen M; Lelie N; Sykes W; Crookes R; Swanevelder J; Gaggia L; Le Roux M; Kuun E; Gulube S; Reddy R Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474 [TBL] [Abstract][Full Text] [Related]
40. Prevalence of anti-HCV antibodies in central India. Jaiswal SP; Chitnis DS; Naik G; Artwani KK; Pandit CS; Salgia P; Sepaha A Indian J Med Res; 1996 Aug; 104():177-81. PubMed ID: 8840656 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]